SCHEMBL16486025

SCHEMBL16486025

Fc1cccc(F)c1-c1[nH]c2ccncc2c1Br

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 3/20 0.47
▸ MAPK14 Q16539 3/20 0.47
▸ PARP1 P09874 2/20 0.43
▸ PDE10A Q9Y233 1/20 0.42
▸ HTR6 P50406 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.40
▸ GABRP O00591 1/20 0.40
▸ GABRD O14764 1/20 0.40
▸ IKBKB O14920 1/20 0.40
▸ AURKA O14965 1/20 0.40
▸ CHUK O15111 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ PIM1 P11309 1/20 0.40
▸ TOP1 P11387 1/20 0.40
▸ GABRA1 P14867 1/20 0.40
▸ IDO1 P14902 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ GABRB1 P18505 1/20 0.40
▸ GABRG2 P18507 1/20 0.40
▸ MAOA P21397 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16486069 0.84 ACHE (0.50) ACHEMAPK14PARP1PDE10AHTR6
SCHEMBL3773933 0.72 CHUK (0.50) ACHEMAPK14PARP1PDE10AKDM4E
SCHEMBL23098918 0.68 ACHE (0.58) ACHEPARP1KDM4EGABRPGABRD
SCHEMBL16485973 0.66 F3 (0.46) MAPK14F7F3CSNK1DCSNK1E
SCHEMBL972999 0.66 ACHE (0.78) ACHEPARP1KDM4EGABRPGABRD
SCHEMBL29642993 0.66 ACHE (0.78) ACHEPARP1KDM4EGABRPGABRD
SCHEMBL121401 0.65 ACHE (1.00) ACHEPARP1HTR6KDM4EGABRP
SCHEMBL29382084 0.65 ACHE (1.00) ACHEPARP1HTR6KDM4EGABRP
SCHEMBL31677485 0.65 ACHE (0.58) ACHEPARP1KDM4EGABRPGABRD
SCHEMBL4819042 0.65 CHUK (0.58) ACHEPARP1KDM4EGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3033342-A1 ANNELATED PYRROLES AND THEIR USE AS CRAC INHIBITORS Grünenthal GmbH (DE) 2016-06-22 — — EP disclosed
US-20160151337-A1 ANNELATED PYRROLES AND THEIR USE AS CRAC INHIBITORS GRUENENTHAL GMBH (DE) 2016-06-02 — — US disclosed
US-20160151337-A1 ANNELATED PYRROLES AND THEIR USE AS CRAC INHIBITORS GRUENENTHAL GMBH (DE) 2016-06-02 — — US disclosed
US-20160151337-A1 ANNELATED PYRROLES AND THEIR USE AS CRAC INHIBITORS GRUENENTHAL GMBH (DE) 2016-06-02 — — US disclosed
WO-2015022073-A1 ANNELATED PYRROLES AND THEIR USE AS CRAC INHIBITORS Grünenthal GmbH (DE) 2015-02-19 — — WO disclosed
WO-2015022073-A1 ANNELATED PYRROLES AND THEIR USE AS CRAC INHIBITORS Grünenthal GmbH (DE) 2015-02-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160151337-A1 ANNELATED PYRROLES AND THEIR USE AS CRAC INHIBITORS AADAC, PRRC2C, PRRC2A ACHE 1693/4885MAPK14 2819/4885PARP1 473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback